Why Technical Readiness Is Not the Bottleneck
Health systems have access to increasingly capable AI models for clinical decision support, documentation assistance, prior authorization automation, and diagnostic screening. The cloud infrastructure exists. The APIs are documented. The models perform well in benchmarks. Yet the vast majority of health systems that pilot clinical AI never reach sustained production use.
The bottleneck is not technical. It is governance. Specifically, it is the absence of clear answers to questions about clinical accountability, bias monitoring, workflow integration, and regulatory alignment. These questions are not optional. They determine whether a clinical AI deployment improves outcomes or creates institutional risk.
Organizations that treat AI deployment as a technology project will pilot endlessly. Those that treat it as a clinical governance initiative will reach production.
Clinical Accountability and the Liability Question
When an AI model recommends a clinical action and a clinician follows that recommendation, who holds accountability for the outcome? This question has not been definitively settled by regulation, and it varies by state, payer contract, and institutional policy.
Health systems deploying clinical AI must establish internal policy that defines the AI as a decision support tool, not a decision maker. This distinction must be documented in clinical protocols, communicated through training, and reinforced in the user interface. If the system presents AI output in a way that suggests definitive clinical guidance rather than supportive information, the liability exposure increases substantially.
The governance framework should specify how AI recommendations are presented to clinicians, under what circumstances a clinician can override the AI, and how those overrides are documented for quality assurance and model improvement.
Bias Monitoring as an Ongoing Obligation
Clinical AI models trained on historical data inherit the biases present in that data. This is well-documented in the literature and has real consequences for patient populations that were underrepresented or systematically disadvantaged in training datasets.
A governance framework for clinical AI must include bias monitoring that is continuous, not one-time. This means defining metrics for differential performance across demographic groups, establishing thresholds that trigger review, and assigning accountability for remediation when bias is detected. Many health systems perform a bias assessment before deployment and then stop monitoring. This is insufficient.
Workflow Integration Determines Adoption
The most clinically accurate AI model in the world will fail if it interrupts clinical workflow rather than supporting it. Deployment teams must work directly with end users to understand where AI output fits into existing workflows, how it should be surfaced in the EHR or care coordination platform, and what the expected response time is.
CDS Hooks and SMART on FHIR provide standardized mechanisms for surfacing AI-driven decision support within EHR workflows. But the technical integration is only half the challenge. The other half is ensuring that the timing, presentation, and clinical relevance of the AI output match the cognitive workflow of the clinician who will use it.
Governance must include a clinical workflow validation process that tests the AI integration with actual users in realistic scenarios before production deployment.